How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PE

NASDAQ:PEPG
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PE

PepGen IncNASDAQ PEPG Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is PEPG undervalued compared to its fair value?

The fair value of PEPG stock is hidden USD. Relative to the market price of 17.59 USD PepGen Inc is hidden.

PepGen Inc. is a biopharmaceutical company. The Company is engaged in developing a transformative oligonucleotide delivery technology and pipeline of product candidates to treat neuromuscular and neurologic diseases. Its...[More about valuation]

PepGen Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

0.551 $B

Price:

17.59 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.979

FINANCIALS

PepGen financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.025 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.023 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.16 B
0.13 B

Financial Position Analysis

Assets

0.16 B
Current Assets
0.13 B
Total non-current assets
0.031 B

Total current liabilities
0.021 B
Total non-current liabilities
0.017 B

Cash Flow Statement

-0.017 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.016 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

PepGen fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

PepGen Rating

Is PEPG attractive for investment based on fundamental analysis?

PEPG stock rating is hidden. PepGen is a hidden by Eyestock methodology.

Get PEPG Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

PEPG analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for PEPG to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

PepGen Inc dividends

PEPG dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About PEPG stock

About the company PepGen Inc

Market cap $B

0.551

Dividend yield

Shares outstanding

23.631924 B

PepGen Inc. is a biopharmaceutical company. The Company is engaged in developing a transformative oligonucleotide delivery technology and pipeline of product candidates to treat neuromuscular and neurologic diseases. Its enhanced delivery oligonucleotide (EDO), platform leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. The Company, through its EDO platform, is developing a pipeline of disease-modifying peptide-conjugated oligonucleotide candidates to treat a variety of degenerative neuromuscular diseases. Its lead product candidates include PGN-EDO51 and PGN-EDODM1. Its lead product candidate, PGN-EDO51, is an EDO peptide conjugated to a phosphorodiamidate morpholino oligomer (PMO) therapeutic cargo, which is developed for the treatment of duchenne muscular dystrophy (DMD) patients with mutations amenable to exon 51-skipping approach. It is also developing PGN-EDODM1, for the treatment of myotonic dystrophy type 1 (DM1).

PEPG profile

  • Ticker

    PEPG

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    06 May 2022

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    31

  • City

    Cambridge

  • Address

    245 Main St, 2nd Floor

  • Cusip

    713317105

Frequently Asked Questions

What sector does PepGen operate in?

PepGen operates in Healthсare sector

What is market cap of PepGen?

Market cap of PepGen is 0.551 USD as of 24 Jul 2024

What is market price of one PEPG stock?

Market price of one PEPG stock is 17.59 USD as of 24 Jul 2024

What is PepGen revenue?

According to the recent report PepGen revenue is —

What is PepGen net income?

According to the recent report PepGen net icnome is -23.29

What is PepGen net income growh rate?

Net income growth rate of PepGen is —